Regulatory requirements for Dossier submission in African Countries (Kenya, Uganda, and Tanzania) - A Review

Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 2

Abstract

Africa is world’s second fastest growing pharmaceutical market. The CGAR of African Pharmaceutical market is 10.6%. African people suffer from numerous diseases. The local pharmaceutical market is weak and insufficient to meet the demand of such diseased condition and so Africa relies heavily on externally developed and procured drugs. This combination of economic strength and prevalence of diseases is already driving a demand for medicines across Africa. The objective of this study is to delve in various parameters required for registration for externally developed pharmaceutical product African countries. A dossier containing detailed information about the drug and results of the studies carried out in its development process has to be submitted to the regulating bodies for getting market authorization. CTD is critical for dossier submissions. A comparative study will help the sponsor to file the dossier in many countries simultaneously; which can save time and money. Thus knowledge of guideline specific for individual country becomes important to determine the most stringent member, which shall ease approval process in other target countries in the region.

Authors and Affiliations

Randeria Juhi, Ronak Dedania, Zarna Dedania, Vineet Jain, Danej Meghna

Keywords

Related Articles

QUALITY STANDARDS FOR MEDICAL DEVICES

Formerly with more augmented disabilities, Medical devices have become decisive device in many circumstances. As these are more perilous, the manufacturer should endow with an ideal medical device in aspects of safety &...

Drug approval process in US, Europe and India and its regulatory requirements: A Review

Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for marketing authorization Application (MAA) approval of new drugs. In this present exertion, study expr...

DRUG REGULATION IN INDIA: SWOT ANALYSIS

Drug regulation plays pivotal role in any country because the purpose of drug regulation is to promote and to protect public health by ensuring the safety, efficacy and quality of drugs. Drug regulation should cover all...

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING TABLETS OF LAFUTIDINE BY EMPLOYING EFFERVESCENT TECHNOLOGY

In the present research work gastro retentive floating matrix formulation of Lafutidine by using various polymers were developed. Initially analytical method development was done for the drug molecule. Absorption maxima...

ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY: A REVOLUTIONIZED LC TECHNIQUE

High Performance Liquid Chromatography (HPLC) is a major technique for qualitative and quantitative drug analysis. More than 90% of drugs prescribed in official pharmacopoeias are being analyzed HPLC. HPLC analyzes the d...

Download PDF file
  • EP ID EP329298
  • DOI 10.22270/ijdra.v6i2.231
  • Views 79
  • Downloads 0

How To Cite

Randeria Juhi, Ronak Dedania, Zarna Dedania, Vineet Jain, Danej Meghna (2018). Regulatory requirements for Dossier submission in African Countries (Kenya, Uganda, and Tanzania) - A Review. International Journal of Drug Regulatory Affairs, 6(2), 14-21. https://europub.co.uk/articles/-A-329298